Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director · President, CEO & Member of BOD | May 22, 2026 | May 26, 2026 |
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director · President, CEO | January 23, 2025 | March 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DENTSPLY SIRONA Inc.
Report date May 22, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 157,754 |
Reported balance
After 2026-05-22 transaction · row 1
1 source rowRow 1 · 2026-05-22 · Tax withholding · Disposed 4,095 · Balance 157,754 F1: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.
GLOBUS MEDICAL INC
Report date January 23, 2025 · Filed March 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $92.42 · Expires 2035-01-23 | Direct | 140,000 |
Reported balance
After 2025-01-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-01-23 · Grant · Acquired 140,000 · Balance 140,000 F1: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2026 Filed May 26, 2026 22:04 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 4,095 | $10.21 | $41,809.95 |
DisclosureSEC source: 0000818479-26-000152 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,754 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:44 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantPhantom Stock (Supplemental Executive Retirement Plan) SERP · Derivative | 3,554.869 | $11.43 | $40,632.15 |
DisclosureSEC source: 0000818479-26-000114 · form4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,554.869 Underlying: Common Stock · 3,554.869 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. F2 · shares: Comprised of phantom stock. F3 · price: Supplemental Executive Retirement Plan (SERP) contribution for the year 2025 based on 12/31/25 closing price. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 2,066,600 | $0.00 Strike: $15.46 | $0.00 |
DisclosureSEC source: 0000818479-26-000101 · form4.xml · derivative · entry 2 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,066,600 Underlying: Common Stock · 2,066,600 shares Expires 2036-03-04 F2 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029, with an exercise price equal to 115% of the closing price of the Issuer's common stock as of the date of grant. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 145,089 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000101 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,839.066 F1 · shares: Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year (3) period ending March 4, 2029. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | Tax withholdingCommon Stock | 1,194.48 | $13.14 | $15,695.47 |
DisclosureSEC source: 0000818479-26-000074 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,750.066 F1 · shares: Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:37 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 245.816 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000036 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,944.546 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:57 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 223.681 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000217 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,698.73 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:25 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 1,102,600 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0000818479-25-000162 · form4.xml · derivative · entry 2 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO & Member of BOD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,102,600 Underlying: Common Stock · 1,102,600 shares Expires 2035-08-08 F1 · derivative.exercise_date: Stock options vest in annual one-third (1/3) increments over a three (3) year period ending August 8, 2028. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 22:03 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 210.049 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-019224 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,475.049 Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:24 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015714 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,265 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:58 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006941 · form4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,385 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 22:53 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 140,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047028 · ownership.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Class A Common Stock · 140,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2026, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:29 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 80,000 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0000950170-24-130588 · ownership.xml · derivative · entry 5 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 80,000 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 22, 2019 and are fully vested. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:29 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 50,000 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0000950170-24-130588 · ownership.xml · derivative · entry 4 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 50,000 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:29 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 130,000 | $85.00 | $11,050,000.00 |
DisclosureSEC source: 0000950170-24-130588 · ownership.xml · nonDerivative · entry 3 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:29 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 80,000 | $43.58 | $3,486,400.00 |
DisclosureSEC source: 0000950170-24-130588 · ownership.xml · nonDerivative · entry 2 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 21:29 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 50,000 | $43.77 | $2,188,500.00 |
DisclosureSEC source: 0000950170-24-130588 · ownership.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0000950170-24-124113 · ownership.xml · derivative · entry 5 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 30,000 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 22, 2018 and are fully vested. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 30,000 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0000950170-24-124113 · ownership.xml · derivative · entry 4 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 30,000 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 30, 2017 and are fully vested. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 60,000 | $80.02 | $4,801,200.00 |
DisclosureSEC source: 0000950170-24-124113 · ownership.xml · nonDerivative · entry 3 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 30,000 | $43.77 | $1,313,100.00 |
DisclosureSEC source: 0000950170-24-124113 · ownership.xml · nonDerivative · entry 2 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:23 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 30,000 | $26.27 | $788,100.00 |
DisclosureSEC source: 0000950170-24-124113 · ownership.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:37 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 140,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008882 · ownership.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Class A Common Stock · 140,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2025, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| October 10, 2023 Filed Oct 19, 2023 21:08 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 10,000 | $0.00 Strike: $53.02 | $0.00 |
DisclosureSEC source: 0001209191-23-053190 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2033-09-01 F1 · derivative.exercise_date: These options were granted on October 10, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 21:49 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 100,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013212 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 100,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 21, 2022 Filed Apr 22, 2022 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 60,000 | $0.00 Strike: $79.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025381 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Class A Common Stock · 60,000 shares Expires 2032-04-21 F1 · derivative.exercise_date: These options were granted on April 21, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on April 21, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 21:44 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 40,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005581 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 50,000 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-21-045825 · doc4.xml · derivative · entry 6 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 50,000 shares Expires 2027-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to buy Class A Common Stock) · Derivative | 50,000 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-21-045825 · doc4.xml · derivative · entry 5 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 50,000 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 400 | $78.97 | $31,588.00 |
DisclosureSEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 4 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 99,600 | $78.41 | $7,809,636.00 |
DisclosureSEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 3 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.83 to $78.69, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 50,000 | $26.27 | $1,313,500.00 |
DisclosureSEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 2 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 50,000 | $25.52 | $1,276,000.00 |
DisclosureSEC source: 0001209191-21-045825 · doc4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2021 Filed Jan 19, 2021 21:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 50,000 | $0.00 Strike: $65.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004035 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2031-01-14 F1 · derivative.exercise_date: These options were granted on January 14, 2021, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2022, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 68,750 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-20-032017 · doc4.xml · derivative · entry 5 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 68,750 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 31,250 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-032017 · doc4.xml · derivative · entry 4 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 31,250 shares Expires 2025-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 100,000 | $55.09 | $5,509,000.00 |
DisclosureSEC source: 0001209191-20-032017 · doc4.xml · nonDerivative · entry 3 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed be the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.47, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 68,750 | $25.52 | $1,754,500.00 |
DisclosureSEC source: 0001209191-20-032017 · doc4.xml · nonDerivative · entry 2 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:30 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 31,250 | $25.40 | $793,750.00 |
DisclosureSEC source: 0001209191-20-032017 · doc4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:39 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 80,000 | $0.00 Strike: $53.27 | $0.00 |
DisclosureSEC source: 0001209191-20-004844 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2030-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 22, 2019 Filed Feb 11, 2019 21:46 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 80,000 | $0.00 Strike: $43.58 | $0.00 |
DisclosureSEC source: 0001209191-19-008986 · doc4.xml · derivative · entry 1 Scavilla Daniel T · CIK 0001642439 · EVP, CFO, Chief Comm. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Class A Common Stock · 80,000 shares Expires 2029-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 31,250 | $0.00 Strike: $25.52 | $0.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · derivative · entry 9 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,750 Underlying: Class A Common Stock · 31,250 shares Expires 2026-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on January 25, 2016, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 50,540 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · derivative · entry 8 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Class A Common Stock · 50,540 shares Expires 2025-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 31,250 | $50.00 | $1,562,500.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 6 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 31,250 | $25.52 | $797,500.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 5 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 50,540 | $50.00 | $2,527,000.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 4 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1. Read SEC document |
| April 10, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 50,540 | $25.40 | $1,283,716.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 3 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 18,210 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · derivative · entry 7 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,790 Underlying: Class A Common Stock · 18,210 shares Expires 2025-04-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 8, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on May 4, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 18,210 | $50.00 | $910,530.96 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 2 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on March 9, 2018, which is intended to comply with Rule 10b5-1. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.04, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| April 09, 2018 Filed Apr 11, 2018 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 18,210 | $25.40 | $462,534.00 |
DisclosureSEC source: 0001209191-18-024686 · doc4.xml · nonDerivative · entry 1 Scavilla Daniel T · CIK 0001642439 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.